Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2025-12-25 @ 1:44 PM
NCT ID: NCT02183792
Description: None
Frequency Threshold: 5
Time Frame: During hospitalization (up to 96 hours post randomization)
Study: NCT02183792
Study Brief: Aquaresis Utility for Hyponatremic Acute Heart Failure Study
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Furosemide Furosemide continuous infusion 5mg/h with option to titrate (with rescue metolazone) Furosemide 0 None 0 15 0 15 View
Tolvaptan Tolvaptan 30-60mg once daily (with rescue loop diuretic or metolazone) Tolvaptan 0 None 0 18 0 18 View
Serious Events(If Any):
Other Events(If Any):